| Trial Status | Recruiting |
| Dates | Date of activation: 21-Nov-08 |
| Data management at EORTC | Full |
| Phase | 1-2 |
| Randomized trial | |
| Type | Hemato-malign |
| Targeted Sample size | EORTC Groups: - - All Groups: 90 |
| Number of steps | 1 |
| Drug | Clofarabine Cytarabine Idarubicin |
| Study Staff | G. Meloni (Study Coordinator) - Universita Di Roma La Sapienza - Clinica Ematologica dell'Università di Roma "La Sapienza", Roma Dominik Selleslag (Study Coordinator) - A.Z. St. Jan, Brugge Roel Willemze (Study Coordinator) - Leiden University Medical Centre, Leiden Stefan Suciu (Statistician) - EORTC Headquarters, Brussels Liv Meert (Data Manager) - EORTC Headquarters, Brussels Safaa Ramadan (Coordinating Physician) - EORTC Headquarters, Brussels Hilde Breyssens (Project Manager) - EORTC Headquarters, Brussels, hilde.breyssens( at )eortc.be, +32 27741004 |
| Type of cancer | |
| Participating Groups | EORTC Leukemia Group(Coordinating Group) Gruppo Italiano Malattie Ematologiche dell'Adulto |
| Centers authorized by EORTC | Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101 A.Z. St. Jan (Brugge, Belgium) - Inst. 109 C.H.U. Sart-Tilman (Liege, Belgium) - Inst. 155 Assistance Publique - Hôpitaux de Paris - Hopital Saint Antoine AP-HP (Paris, France) - Inst. 203 Universita Di Roma La Sapienza - Clinica Ematologica dell'Università di Roma "La Sapienza" (Roma, Italy) - Inst. 733 Azienda Ospedallera Universitaria - Policlinico Tor Vergata (Roma, Italy) - Inst. 3931 Jeroen Bosch Ziekenhuis ('s-Hertogenbosch, The Netherlands) - Inst. 22 Radboud University Nijmegen Medical Centre (Nijmegen, The Netherlands) - Inst. 304 |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00838240 |
| EudraCT | 2006-004912-28 |
| Protocol documents in PDF (requires password) | Study documentation |